ProstaLund
0.259
SEK
0 %
PLUN
First North Stockholm
Medical Equipment & Services
Health Care
Be the first to follow this company
0%
-13.67%
-28.65%
-52.72%
-83.47%
-84.1%
-94.14%
-91.2%
-97.16%
prostalund.se
ProstaLund operates in medical technology. Today, specialisation is mainly in the area of treatment of benign prostate enlargement (BPH). Through the company CoreTherm, heat treatment of benign prostate enlargement is offered, without the need for surgical operation. The vision is to offer both faster and more efficient solutions against traditional forms of infestation. The company was founded in 1991 and is operating globally, based in Lund.
Revenue
22.21M
EBIT %
-75.87 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
PLUN
Daily low / high price
0.251 / 0.259
SEK
Market cap
37.55M SEK
Turnover
8.79K SEK
Volume
34K
Financial calendar
Extraordinary general meeting
2024-12-05
Annual report
2025-02-20
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Mats Alyhr | 22.4 % | 22.4 % |
| Försäkringsaktiebolaget, Avanza pension | 9.0 % | 9.0 % |
| BFCM P/C BFCM Sweden Retail LT | 5.5 % | 5.5 % |
| Ålandsbanken | 3.3 % | 3.3 % |
| Nordnet Pensionsförsäkring | 2.8 % | 2.8 % |
| SEB Life International | 2.3 % | 2.3 % |
| Fenja Capital i A/S | 1.8 % | 1.8 % |
| Oskar Alyhr | 1.6 % | 1.6 % |
| Nilsson, Arve | 1.4 % | 1.4 % |
| Wiese, Hartmut | 1.3 % | 1.3 % |
ShowingAll content types
Teckningskursen för nyttjande av teckningsoptioner serie TO 3 i ProstaLund har fastställts till 0,17 SEK och nyttjandeperioden inleds den 18 november 2024
Västra Hamnen Market Focus: ProstaLund: CoreTherm Eagle flygfärdig
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools